MY120631A - Novel pharmaceutical combination having analgesic activity - Google Patents

Novel pharmaceutical combination having analgesic activity

Info

Publication number
MY120631A
MY120631A MYPI20004168A MY120631A MY 120631 A MY120631 A MY 120631A MY PI20004168 A MYPI20004168 A MY PI20004168A MY 120631 A MY120631 A MY 120631A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical combination
novel pharmaceutical
analgesic activity
novel
buspirone
Prior art date
Application number
Inventor
Francoise Camborde
Alix Cloarec
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Priority to MYPI20004168 priority Critical patent/MY120631A/en
Publication of MY120631A publication Critical patent/MY120631A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THE AIM OF THE PRESENT INVENTION IS A NOVEL PHARMACEUTICAL COMBINATION , CHARACTERISED IN THAT IT COMPRISES, AS COMBINED ACTIVE PRINCIPLES , PARACETAMOL AND BUSPIRONE OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS.
MYPI20004168 2000-09-08 2000-09-08 Novel pharmaceutical combination having analgesic activity MY120631A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20004168 MY120631A (en) 2000-09-08 2000-09-08 Novel pharmaceutical combination having analgesic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20004168 MY120631A (en) 2000-09-08 2000-09-08 Novel pharmaceutical combination having analgesic activity

Publications (1)

Publication Number Publication Date
MY120631A true MY120631A (en) 2005-11-30

Family

ID=47257116

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20004168 MY120631A (en) 2000-09-08 2000-09-08 Novel pharmaceutical combination having analgesic activity

Country Status (1)

Country Link
MY (1) MY120631A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435505A (en) * 1981-12-11 1984-03-06 The United States Of America As Represented By The Department Of Health And Human Services Lysis filtration culture chamber
US4576953A (en) * 1983-03-29 1986-03-18 Imperial Chemical Industries Plc Quinoline derivatives
US4607039A (en) * 1982-05-04 1986-08-19 Imperial Chemical Industries Plc Quinoline derivatives which are 5-hydroxytryptamine antagonists

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435505A (en) * 1981-12-11 1984-03-06 The United States Of America As Represented By The Department Of Health And Human Services Lysis filtration culture chamber
US4607039A (en) * 1982-05-04 1986-08-19 Imperial Chemical Industries Plc Quinoline derivatives which are 5-hydroxytryptamine antagonists
US4576953A (en) * 1983-03-29 1986-03-18 Imperial Chemical Industries Plc Quinoline derivatives

Similar Documents

Publication Publication Date Title
NO2025027I1 (en) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - extended.
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
MY129356A (en) Electrospun pharmaceutical compositions
DE69925133D1 (en) PYRROLOBENZODIAZEPINE
GEP20074047B (en) Pramipexole once-daily dosage form
PL350456A1 (en) N−cyanomethylamides as protease inhibitors
MXPA03007712A (en) Pharmaceutical salts.
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
MXPA05003253A (en) Novel pyrimidineamide derivatives and the use thereof.
SE9802208D0 (en) Novel compounds
WO2005007137A3 (en) Tablets containing ambroxol
MXPA03010761A (en) Pharmaceutical combinations.
GB0002336D0 (en) Medicaments
MXPA03008420A (en) Solid orally-dispersible pharmaceutical formulation.
MXPA03005221A (en) Pharmaceutical dronedarone composition for parenteral administration.
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
ZA200107143B (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders.
SE9802209D0 (en) Novel compounds
EE05241B1 (en) Use of the α-halogenoacryl derivative of distamycin
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
AU2002224896A1 (en) Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
CY1108053T1 (en) UNION OF CYAMEMAZINE AND A FORMULATED NEUROLIPTIC